Clarification
With reference to increase in Volume, Alkem Laboratories Ltd has submitted to BSE a copy of Clarification is enclosed.20-06-2016
20-06-2016
Clarification sought from Alkem Laboratories Ltd
The Exchange has sought clarification from Alkem Laboratories Ltd on June 20, 2016, with reference to increase in Volume.The reply is awaited.20-06-2016
Clarifies on news item
With reference to the news appeared in the newspaper Business Standard "Drug regulator finds Alkem Labs drug substandard", Alkem Laboratories Ltd has submitted to BSE a copy of Clarification is enclosed.09-06-2016
Clarification sought from Alkem Laboratories Ltd
The Exchange has sought clarification from Alkem Laboratories Ltd with reference to the news appeared in the newspaper Business Standard "Drug regulator finds Alkem Labs drug substandard"The reply is awaited.09-06-2016
Drug regulator finds Alkem Labs drug sub-standard again
It's the third alert to be issued in the past one year for the anti-diabetic drug; but no recall this time08-06-2016
Alkem Laboratories' Taloja facility cleared by UK health regulator
The UKMHRA has given a clean chit to Alkem Laboratories' Taloja facility after going through the corrective and preventive steps the company submitted07-06-2016
Alkem announces closure of UK-MHRA inspection for its Bioequivalence Facility at Taloja
Alkem Laboratories Ltd has informed BSE regarding a Press Release dated June 07, 2016 titled "Alkem announces closure of UK-MHRA inspection for its Bioequivalence Facility at Taloja".07-06-2016
Opening of Trading Window
With reference to the earlier letter dated March 29, 2016 regarding closure of trading window (for the purpose of financial results for the quarter and year ended March 31, 2016) starting from March 30, 2016 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter and year ended on March, 2016 are communicated to the Stock Exchanges....27-05-2016
Standalone & Consolidated Financial Results, Form A, Auditors Report, Results Press Release, Result Presentation for March 31, 2016
Alkem Laboratories Ltd has informed BSE about : 1. Standalone Financial Results for the period ended March 31, 20162. Consolidated Financial Results for the period ended March 31, 20163. Standalone Form A for the period ended March 31, 20164. Consolidated Form A for the period ended March 31, 20165. Standalone Auditors Report for the period ended March 31, 2016...27-05-2016